Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
Conditions
- Lung Diseases, Interstitial
- Systemic Sclerosis
- Scleroderma
Interventions
- DRUG: Bortezomib
- DRUG: Placebo
- DRUG: Mycophenolate mofetil
Sponsor
Northwestern University
Collaborators